Lutikizumab (ABT-981) met its primary end point and all 8 ranked secondary end points in the phase 3 INTREPID trial ...

Shannon Trotter, DO, moderated a Dermatology Times Case-Based Roundtable event on how pharmacokinetics, adverse event timing, and trial response criteria should shape hedgehog pathway inhibitor ...

Join host Cynthia Trickett, MPAS, PA-C, for a video podcast on hidradenitis suppurativa (HS), joined by Leigh Ann Pansch, MSN, FNP-BC, DCNP; Buchi Neita, PA-C, MCMSc; and Victor Czerkasij, DCNP, FNP-C ...

SPD 2026 highlighted advances in pediatric dermatology spanning textured hair care, vitiligo, vascular anomalies, mental ...

Dermatology Times will host its 3rd annual Horizons in Advanced Practice meeting on October 23, 2026, in Atlanta, Georgia.

Rocco Serrao, MD, FAAD, a board-certified dermatologist, discusses a case of vitiligo involving a 20-year-old male patient who presents with white patches on his face that have persisted for 6 weeks ...

Dr. Singh presents a 76-year-old woman with a 6-year history of recurrent basal cell carcinoma involving the nasal sidewall ...

A young construction worker managed with photoprotection alone continues to have breakthrough phototoxicity and mildly ...

The American Academy of Dermatology (AAD) and Hidradenitis Suppurativa Foundation (HSF) have issued their first joint ...

Clinicians at a Dermatology Times Case-Based Roundtable, moderated by Chesahna Kindred, MD, debated when to escalate to oral JAK inhibitors for alopecia areata and how to counsel patients on timing, ...

Skin longevity is on a path to becoming a legitimate and consequential area of dermatology. For it to fully succeed, skin ...

Angela Fitch, MD, co-founder and chief medical officer of Knownwell, discussed GLP-1 access strategies and a proposed ...